All filters
Videos
All infants should receive oral antiretroviral prophylaxis throughout breastfeeding | Philippe van der Perre, MD, PhD
Presented at:
International Workshop on HIV & Pediatrics 2018
Videos
All infants should receive oral antiretroviral prophylaxis throughout breastfeeding | Amy Slogrove, MB ChB, MMed, PhD
Presented at:
International Workshop on HIV & Pediatrics 2018
Videos
Debate:All infants should receive oral antiretroviral prophylaxis throughout breastfeeding
Presented at:
International Workshop on HIV & Pediatrics 2018
Videos
Mobile technology for engaging children and youth in treatment and prevention | Lisa Hightow-Weidman MD, MPH
Presented at:
International Workshop on HIV & Pediatrics 2018
Videos
Clinical case presentations | Moherndran Archary
Presented at:
International Workshop on HIV & Pediatrics 2018
Videos
Clinical case presentations | Gareth Tudor Williams
Presented at:
International Workshop on HIV & Pediatrics 2018
Videos
HIV vaccines and broadly neutralizing monoclonal antibody - role in the cure agenda | Sandhya Vasan, MD
Presented at:
International Workshop on HIV & Pediatrics 2018
Videos
Controllers: post-treatment vs elite controllers – what do we know? | Phillip Goulder, MA, FRCPCH, DPhil, FMedSc
Presented at:
International Workshop on HIV & Pediatrics 2018
Videos
Early treatment and clinical outcomes – does early ART make a difference? | Louise Kuhn, PhD
Presented at:
International Workshop on HIV & Pediatrics 2018
Videos
Debate: All children should be switched to dolutegravir-based ART regimens | Nandita Sugandhi
Presented at:
International Workshop on HIV & Pediatrics 2018
Videos
Debate: All children should be switched to dolutegravir-based ART regimens | Adeodata Kekitiinwa, MBChB, MMed
Presented at:
International Workshop on HIV & Pediatrics 2018
Videos
Roundtable Discussion: Optimal Management of INSTI Toxicity and Co-Morbidities in the Asian Setting
Presented at:
Chinese HIV Clinical Forum Educational Series 2020 - 2021
Videos
Managing Toxicities and Co-Morbidities
Presented at:
Chinese HIV Clinical Forum Educational Series 2020 - 2021
Slidesets
Managing Toxicities and Co-Morbidities
Presented at:
Chinese HIV Clinical Forum Educational Series 2020 - 2021
Videos
Recap the Third Edition
Presented at:
Chinese HIV Clinical Forum Educational Series 2020 - 2021
Videos
Reduced drug regimens - their place in routine practice | Omar Sued, MSc, MD, PhD
Presented at:
Brazilian HIV Clinical Forum 2018
Videos
Optimal use of Integrase Inhibitors in routine clinical practice | Carlos Brites, MD, PhD
Presented at:
Brazilian HIV Clinical Forum 2018
Videos
Clinical Case presentation | Fabianna Bahia, MD, PhD
Presented at:
Brazilian HIV Clinical Forum 2018
Videos
Resistance Characteristics of Integrase Inhibitors | Charles Boucher, MD, PhD
Presented at:
Brazilian HIV Clinical Forum 2018
Videos
Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors | David Back, PhD
Presented at:
Brazilian HIV Clinical Forum 2018
Videos
Transitioning to use of Integrase Inhibitors in Brazil | Estevão Nunes
Presented at:
Brazilian HIV Clinical Forum 2018
Videos
The Integrase Inhibitors drug class: a comparative clinical review | Ian Frank
Presented at:
Brazilian HIV Clinical Forum 2018